495 filings
Page 8 of 25
8-K
APVO
Aptevo Therapeutics Inc
21 Jan 22
Departure of Directors or Certain Officers
8:15am
4
APVO
Aptevo Therapeutics Inc
7 Dec 21
Aptevo Therapeutics / Fuad El-Hibri ownership change
9:09pm
4
APVO
Aptevo Therapeutics Inc
26 Nov 21
Aptevo Therapeutics / KEVIN C TANG ownership change
1:02pm
SC 13D/A
APVO
Aptevo Therapeutics Inc
26 Nov 21
Aptevo Therapeutics / TANG CAPITAL PARTNERS ownership change
1:00pm
8-K
APVO
Aptevo Therapeutics Inc
23 Nov 21
Other Events
8:18am
SC 13D/A
Tang Capital Partners LP
22 Nov 21
Aptevo Therapeutics / TANG CAPITAL PARTNERS ownership change
5:28pm
4
APVO
Aptevo Therapeutics Inc
22 Nov 21
Aptevo Therapeutics / KEVIN C TANG ownership change
5:26pm
8-K
APVO
Aptevo Therapeutics Inc
12 Nov 21
Aptevo Therapeutics Reports Third Quarter Financial Results with Business Highlights
8:16am
10-Q
2021 Q3
APVO
Aptevo Therapeutics Inc
Quarterly report
12 Nov 21
8:11am
8-K
APVO
Aptevo Therapeutics Inc
5 Nov 21
Entry into a Material Definitive Agreement
4:15pm
8-K
APVO
Aptevo Therapeutics Inc
27 Aug 21
Departure of Directors or Certain Officers
9:00am
EFFECT
APVO
Aptevo Therapeutics Inc
20 Aug 21
Notice of effectiveness
12:15am
8-K
APVO
Aptevo Therapeutics Inc
17 Aug 21
Aptevo Therapeutics Announces APVO436 Monotherapy is Active in Patients Who Have Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome
8:35am
UPLOAD
APVO
Aptevo Therapeutics Inc
17 Aug 21
Letter from SEC
12:00am
CORRESP
APVO
Aptevo Therapeutics Inc
17 Aug 21
Correspondence with SEC
12:00am
S-3
APVO
Aptevo Therapeutics Inc
Shelf registration
12 Aug 21
4:46pm
8-K
APVO
Aptevo Therapeutics Inc
12 Aug 21
Aptevo Therapeutics Reports Second Quarter Financial Results with Business Highlights
4:11pm
10-Q
2021 Q2
APVO
Aptevo Therapeutics Inc
Quarterly report
12 Aug 21
4:05pm
8-K
APVO
Aptevo Therapeutics Inc
28 Jun 21
Submission of Matters to a Vote of Security Holders
5:15pm
DEFA14A
APVO
Aptevo Therapeutics Inc
21 Jun 21
Additional proxy soliciting materials
5:25pm